Call Buying Activity in Amarin Corp. (AMRN) Targets Upside in Shares Follow Q4 Earnings Beat -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Amarin Corporation (AMRN) PT Lowered to $12 at Oppenheimer
February 26, 2020 7:13 AM ESTOppenheimer analyst Leland Gershell lowered the price target on Amarin Corporation (NASDAQ: AMRN) to $12.00 (from $13.00) while maintaining an Underperform rating.
The analyst commented, "Amarin's 4Q19 Vascepa sales of $142.0M (+85% year/year) brought FY19 total revenue to $429.8M, just above upper end of... More
Amarin Corporation (AMRN) Litigation Decision Expected in March, Possible Catalyst This Friday - Citi
February 26, 2020 6:29 AM ESTCiti analyst Joel Beatty reiterated a Buy rating and $24.00 price target on Amarin Corporation (NASDAQ: AMRN) ahead of the company's ANDA court decision next month which the analyst believes will be resolved positively. Post-trial briefs from are expected to be publicly available on... More
Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms
February 25, 2020 4:12 PM ESTAmarin Corp. (NASDAQ: AMRN) reported Q4 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $143.3 million versus the consensus estimate of $136.01 million.
2019 was a transformational year for Amarin and for preventative cardiovascular patient care, commented John Thero, Amarins... More
